CSPC Pharmaceutical (1093 HK) – Steady Finished Drug Sales

338 Views25 Aug 2023 07:42
Broker
The adjusted attributable net profit (excl. impact from fair value change of financial assets and share-based compensation) in 1H23 increased 3.0% YoY to RMB3.16bn.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 12-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
CMB International
External broker reports(aggregated public sources)
CMB International
China & Hong KongEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x